Literature DB >> 29305302

Actual state of knowledge in the field of diseases related with defective nucleotide excision repair.

Barbara Bukowska1, Bolesław T Karwowski2.   

Abstract

Xeroderma pigmentosum (XP), trichothiodystrophy (TTD) and Cockayne syndrome (CS) are rare genetic diseases characterized by a large range of clinical symptoms. However, they are all associated with defects in nucleotide excision repair (NER), the system responsible for removing bulky DNA lesions such as those generated by UV light: cyclobutane pyrimidine dimers (CPDs) and pyrimidine-pyrimidone photoproducts (6-4 PPs). Over the past years, detailed structural and biochemical information on NER-associated proteins has emerged. In the first part of the article we briefly present the main steps of the NER pathway with an emphasis on the precise role of certain proteins. Further, we focus on clinical manifestations of the disorders and describe the diagnostic procedures. Then we consider how current therapy and advanced technology could improve patients' quality of life. Although to date the discussed diseases remain incurable, effective sun protection, a well thought out diet, and holistic medical care provide longer life and better health. This review summarizes the current state of knowledge regarding the epidemiology of NER-associated diseases, their genetic background, clinical features, and treatment options.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cockayne syndrome; Neurological abnormalities; Nucleotide excision repair; Photosensitivity; Trichothiodystrophy; Xeroderma pigmentosum

Mesh:

Year:  2018        PMID: 29305302     DOI: 10.1016/j.lfs.2017.12.035

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Coupling between nucleotide excision repair and gene expression.

Authors:  Adrián E Cambindo Botto; Juan C Muñoz; Manuel J Muñoz
Journal:  RNA Biol       Date:  2018-05-17       Impact factor: 4.652

2.  Genomic analysis of Rad26 and Rad1-Rad10 reveals differences in their dependence on Mediator and RNA polymerase II.

Authors:  Diyavarshini Gopaul; Cyril Denby Wilkes; Arach Goldar; Nathalie Giordanengo Aiach; Marie-Bénédicte Barrault; Elizaveta Novikova; Julie Soutourina
Journal:  Genome Res       Date:  2022-06-23       Impact factor: 9.438

Review 3.  Biomarkers of Cellular Senescence and Skin Aging.

Authors:  Audrey S Wang; Oliver Dreesen
Journal:  Front Genet       Date:  2018-08-23       Impact factor: 4.599

4.  Variant subtype of xeroderma pigmentosum with multiple basal cell carcinomas diagnosed in a Chinese woman.

Authors:  Na Zhang; Xuefeng Fu; Xiaoxiao Chen; Lin Chen; Meiyan Wang
Journal:  Photodermatol Photoimmunol Photomed       Date:  2020-11-05       Impact factor: 3.135

Review 5.  Integrating the DNA damage and protein stress responses during cancer development and treatment.

Authors:  Vassilis G Gorgoulis; Dafni-Eleftheria Pefani; Ioannis S Pateras; Ioannis P Trougakos
Journal:  J Pathol       Date:  2018-07-19       Impact factor: 7.996

Review 6.  Identification of a novel DDB2 mutation in a Chinese Han family with Xeroderma pigmentosum group E:a case report and literature review.

Authors:  Rui Yang; Qingtao Kong; Yuanyuan Duan; Weiwei Li; Hong Sang
Journal:  BMC Med Genet       Date:  2020-03-30       Impact factor: 2.103

7.  Single molecule analysis reveals monomeric XPA bends DNA and undergoes episodic linear diffusion during damage search.

Authors:  Emily C Beckwitt; Sunbok Jang; Isadora Carnaval Detweiler; Jochen Kuper; Florian Sauer; Nina Simon; Johanna Bretzler; Simon C Watkins; Thomas Carell; Caroline Kisker; Bennett Van Houten
Journal:  Nat Commun       Date:  2020-03-13       Impact factor: 14.919

8.  How (5'S) and (5'R) 5',8-Cyclo-2'-Deoxypurines Affect Base Excision Repair of Clustered DNA Damage in Nuclear Extracts of xrs5 Cells? A Biochemical Study.

Authors:  Karolina Boguszewska; Michał Szewczuk; Julia Kaźmierczak-Barańska; Bolesław T Karwowski
Journal:  Cells       Date:  2021-03-24       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.